Fish oil supplementation reduces the CERT2 risk score in adults with increased cardiometabolic risk: Findings from the MoKaRi trial pubmed.ncbi.nlm.nih.gov
Check the source before sharing
Open the submitted source. Look for its author, publication date, and links to the underlying report or document. Community submissions and discussion labels are not automatic fact checks.
Fish oil supplementation reduces the CERT2 risk score in adults with increased cardiometabolic risk: Findings from the MoKaRi trial
CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events
Cardiometabolic refers to the combined health of your cardiovascular system (heart and blood vessels) and metabolic system (how your body processes food into energy).
Follow this discussion
More coverage
No reviewed related coverage has been linked to this story yet.
Reader context
No reader context has been approved for this story yet.
Suggest sourced context or a correction
Add relevant background or a correction with supporting evidence. Suggestions are reviewed before display. Review is not a guarantee that a claim is true.

Share Your Take
What do you think about this story? Add your voice to the Twellit community.